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Low aqueous solubility prevents 40-70% of new pharmaceutical agents from 
reaching their full potential. The use of molecular containers as solubilizing agents is one 
solution currently under development. Chapter 1 introduces molecular containers under 
investigation as drug delivery excipients. Synthetic approaches, properties and important 
derivatives of cyclodextrins and cucurbiturils are briefly reviewed. Chapter 2 describes 
the tested hypothesis that the addition of sulfonate functional groups to CB[7] will 
enhance the aqueous solubility of the CB[7] derivative as compared to CB[7] itself.  The 
building-block approach to obtain a difunctionalized CB[7] derivative by the 
condensation of glycoluril hexamer (21) and ((CH2)4SO3Na)2 glycoluril bis(cyclic ether) 
(30) is described. The new CB[7] derivative had surprisingly low aqueous solubility (20.2 
mM), but very similar molecular recognition properties to those of CB[7]. The CB[7] 
derivative was investigated for its use as an excipient for drug solubilization and found to 
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Chapter 1: Molecular Containers 
 
1.1 Introduction to Molecular Containers 
Solubility issues often overshadow the excitement of discovering a new 
compound with pharmaceutical activity. Approximately 40-70% of new pharmaceutical 
agents fall into the Biopharmaceutics Classification System Class II.1 These compounds 
exhibit the high intestinal permeability required for a successful pharmaceutical agent, 
but suffer from low aqueous solubility. This limitation has led researchers to devote 
significant resources to the discovery of methods to enhance the solubility of these 
potential pharmaceuticals. One solution with great promise is the use of molecular 
containers as excipients.  
Molecular containers are an interesting group of compounds that are able to 
recognize and associate with another molecule through non-covalent interactions. The 
strength of the association is based on the strength of intermolecular interactions such as 
hydrogen bonding, ion-dipole, dipole-dipole, π-π, metal coordination, the hydrophobic 
effect and van der Waals forces. The field of supramolecular chemistry has greatly 
expanded with the discovery of different families of molecular containers as well as their 
innumerable applications. This chapter will focus on two families of molecular containers 
(cyclodextrins and cucurbiturils) that are currently under investigation for their use as 
excipients for drug solubilization. 
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1.2 Cyclodextrins: A family of bowl-shaped molecular containers 
Cyclodextrins (CDs) are cyclic oligosaccharides composed of α-D-glucose units 
linked by α-1,4 glycosidic bonds that are obtained by enzymatic degradation of starch. 
They first appeared in literature in 1891 when Villiers and co-workers noticed that along 
with reducing dextrins a small amount of crystalline material was obtained from starch 
digestion of Bacilus amylobacter.2 By 1935 the more prevalent CDs (6-8 α-D-glucose 
units per macrocycle) known as α-, β-, and γ-CD were isolated.3 Interestingly, it took an 
additional 14 years for all three structures to be determined by x-ray crystallography 
(Chart I-1).4 The identified bowl-like structure makes them compelling molecular 
containers.  
  
Chart I-1. Chemical structures of α-, β-, and γ-CD. 
The unique structure of CDs controls their properties. They have two rims of 
different sizes that are flanked with hydroxyl groups. These hydroxyl groups are 
advantageous in two ways: their hydrophilic nature increases the water solubility of the 
macrocycle (α-CD: 149 mM, β-CD: 16 mM, γ-CD: 178 mM)5 and are able to form 
hydrogen bonds with appropriate guests. Hydrogens and ether-like oxygens point inward 
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nature. These features, when combined, make CDs able to act as molecular containers for 
alkyl and aryl residues especially if they contain motifs able to hydrogen bond with one 
of the hydroxyl groups of one of the rims. 
Complexation between a CD and a guest is the result of a complicated 
equilibrium. In fact, a combination of energetically favorable interactions is required for 
complexation to occur. Dissolution of CDs in aqueous media results in water molecules 
encompassing the apolar cavity that gives rise to a highly energetic, highly ordered water 
molecule arrangement.5 Therefore it is thermodynamically favorable to displace the water 
molecules with an alkyl or aryl guest molecule. Another contributing factor is the 
increase in van der Waals interactions between the apolar cavity and guest. Hydrogen 
bonding between a guest and a hydroxyl group on one of the rims can also aid in 
complexation. The combination of these interactions makes complexation a 
thermodynamically favorable process. 
The glycosidic linkages between the individual sugar units of the CD macrocycles 
make the bowl-like structure fairly flexible. This flexibility makes the cavity able to bind 
a wide variety of guests. A single β-CD can form a host•guest complex with molecules 
ranging from 1-propanol (4) to protriptyline (5) (Chart I-2).6 Not surprisingly, the 
strength of the complex is dependent on favorable electrostatic interactions as well as 
hydrogen bonding between the guest and the CD hydroxyl rim. Naphthalene (6) 
association with β-CD, Ka = 6.7 × 102 M-1, is a result of the hydrophobic effect while 1-
naphthalene acetate (7) forms a much stronger complex with Ka = 2.2 × 104 M-1 because 
of hydrogen bonding as well as the hydrophobic effect.7,8 This dependence on hydrogen 
bonding makes CD•guest complexation stimuli-responsive. A change in pH from 8.2 to 
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1.6 results in a slight increase in Ka from 2.3 × 102 to 4.3 × 102 M-1 for trans-3-
hydroxycinnamate (8) with β-CD in aqueous solution.9 The Ka for many CD•guest 
complexes are dependent on changes in the pH of the solution. 
  
Chart I-2. Chemical structures for β-CD guests (1-propanol (4), protriptyline (5), 
napththalene (6), 1-naphthalene acetate (7), trans-3-hydroxycinnamate (8)). 
 
The ease of derivitization of the 1° and 2° hydroxyl groups along the rims of the 
CD’s have allowed for many derivatives to be synthesized. One example of a CD 
derivative currently being employed as a drug delivery excipient is Captisol™. 
Captisol™ (also known as SBE7-β-CD where 7 refers to the average degree of 
substitution) is a derivative of β-CD with an average of 7 sulfobutyl ether sodium salt 
arms variably substituted along the rims.10 The anionic CD has highly enhanced water 
solubility (>500 mM)11 and has been shown to form highly soluble host•guest complexes 
with a wide variety of pharmaceuticals (i.e. indomethacin (9), thiabendazole (10), 
naproxen (11), and cinnarizine (12) (Chart I-3). Although CDs suffer from relatively low 
Ka’s and poor selectivity, they have been proven to be useful molecular containers for 











Chart I-3. Chemical structures for Captisol™ and insoluble drugs (indomethacin (9), 
thiabendazole (10), naproxen (11), and cinnarizine (12)). 
1.3 Cucurbiturils: A family of open-ended barrel-like molecular containers  
 1.3.1 Introduction to Cucurbiturils 
 
In 1905, Behrend and co-workers reported that the condensation reaction between 
glycoluril and two equivalents of formaldehyde in concentrated hydrochloric acid 
delivered a compound now known as Behrend’s polymer.12 Little was known about 
Behrend’s polymer other than its dissolution in hot sulfuric acid, upon which the addition 
of cold water would lead to a new substance as a crystalline precipitate. Unfortunately, 
the limited instrumentation techniques of that time prevented full characterization. 
Behrend’s results were not revisited until 1981, over 75 years after the initial publication, 
when Mock and co-workers repeated Behrend’s experiment. The crystalline precipitate 
was collected and characterized (Scheme I-1).13 The IR suggested the preservation of the 
glycoluril subunits (1720 cm-1, KBr). The presence of only three signals of equivalent 
intensity in the 1H NMR indicated a molecule with very high symmetry. X-ray 
crystallography was used to determine the structure of a complex formed between the 
























































precipitate under the name cucurbituril (later referred to as cucurbit[6]uril) based on the 
resemblance of the structure to a pumpkin (family Cucurbitaceae). 
 
Scheme I-1. Glycoluril condensation reaction to form Behrend’s polymer and the 
transformation to CB[6].  
 
By performing the reaction under milder kinetically controlled conditions, Day 
and Kim independently expanded the cucurbit[n]uril (CB[n]) family by the isolation of 
additional CB[n] (n = 5-8), where n represents the number of glycoluril units in the 
macrocycle (Scheme I-2).14,15 Isaacs reported the isolation of the largest CB[n] 
macrocycle, CB[10], in 2005.16 The isolation of these different macrocycles allowed the 
unique properties of the CB[n] homologues to be fully investigated.  
 
Scheme I-2. Glycoluril condensation reaction to form CB[n]. 
 
The solubility of the CB[n] homologues is dependent on the ability of the 
macrocycles to self-associate in the crystalline state.17 The strength of the association is 
affected by the number of inter-cucurbituril CH---O interactions between the equatorial 
methine protons and the ureidyl carbonyl portal of a neighboring CB[n]. Interestingly, the 
































































































1 equiv. 2 equiv.
 7 
 
interactions. This efficient crystal packing provides an explanation for the observed low 
aqueous solubility of CB[6], CB[8], and CB[10] (< 20 µM). The CB[n] homologues with 
an odd number of glycoluril units, CB[5] and CB[7], have less efficient crystal packing 
and moderate solubilities (20-30 mM). An aqueous solubility enhancement is observed 
for all CB[n] homologues under acidic conditions or in the presence of certain cations 
due to the interactions between the electrostatically negative ureidyl carbonyl portals of a 
CB[n] and the positively charged ion (i.e. alkali metals, alkyl and aryl ammonium ions). 
This ability to capture a guest molecule inside the cavity makes the CB[n] homologues 
compelling compounds. 
Many interactions affect the ability of a CB[n] to strongly bind a specific guest. 
Each CB[n] has a fairly rigid structure resulting in a level of selectivity not seen in 
previous molecular containers. Favorable electrostatic interactions play a large role in 
CB[n]•guest binding. The carbonyl portals and hydrophobic cavity make CB[n] ideal 
hosts for hydrophobic and cationic guests in water by hydrogen-bonding, ion-dipole 
interactions, and the hydrophobic effect. The varying cavity sizes of the CB[n] allow for 
each macrocycle to interact with a set of guests based on their size. Upon solubilization, 
the cavity is filled with high-energy water molecules that can be displaced by an 
appropriate guest. Strong host•guest complexes can form between a CB[n] and guests of 
appropriate size that are able to interact with one or both carbonyl portals, such as alkyl 




Scheme I-3. a) Equilibrium of complexation between hexanediamine and CB[6]. b) 
Ammonium guests of various sizes and positive charges able to interact with CB[n] 
(hexanediamine•2HCl (13), adamantane amine•HCl (14), p-phenylenediamine•2HCl 
(15), p-xylenediamine•2HCl (16)). 
 
 The formation of a complex is highly dependent on favorable electrostatic 
interactions between positively charged ammonium ions and the carbonyl portal. The 
binding interactions are less favorable if the ammonium ion is deprotonated and the 
strength of the complex will decrease by up to 4 orders of magnitude. This decrease often 
will result in guest dissociation. Excitingly, this dependence on electrostatic interactions 
makes the binding responsive to stimuli, such as pH. The hydrogen-bond between the 
carbonyl of the CB[n] and the diammonium ion stabilizes the charge, which can result in 
a pKa shift in many cases. Nau and co-workers reported a pKa shift of +4.0 for 
thiabendazole 10 upon complexation with CB[7].19 The large pKa shift allows for 
complexation at higher pH’s, making CB[n] ideal molecular containers to bind and 
stabilize certain compounds at pH values not possible for the free compound. These 
unique properties have led to many exciting advances in CB[n]-assisted drug delivery. 
The strength of the host•guest complex is highly dependent on the fit of the guest 
inside the cavity, making guests of different sizes ideal for binding to each of the CB[n]. 
The association equilibrium constant Ka has been determined for many host•guest 
complexes in a 50 mM sodium acetate buffer.20 The hexanediammonium ion (13) is the 


























































































lower affinity for 13, Ka = 8.87 × 107 M-1, but is perfect for the larger carbon skeleton of 
the adamantane ammonium ion (14) with Ka = 4.23 × 1012 M-1. Not surprisingly, the 
strongest complexes will form when there is an ideal match between the size of the cavity 
and the size of the guest. 
 The high water solubility (as compared to CB[6] and CB[8]), ideal cavity size, 
and reversible binding of CB[7] have made it the most widely studied CB[n] homologue. 
These specific characteristics give it potential as a molecular container for drug delivery 
(Chart I-4). Albendazole (17), an anti-parasitic drug with potential anti-cancer properties, 
has poor aqueous solubility (0.03 mM) at a neutral pH.21 A significant solubility 
enhancement to 7.1 mM (>200-fold) was obtained in a 10 mM solution of CB[7].21 The 
anti-cancer drug camptothecin (18), is insoluble in water at pH = 7.4 and is only slightly 
soluble at pH = 2 (0.0595 mM).22 In the presence of a 7.6 mM CB[7] solution at pH = 
2.0, however, the water solubility is enhanced to 4 mM (67-fold). These impressive 
solubility enhancements show great promise for the use of CB[n] as a solubilizing 
excipient for the purpose of drug delivery. 
 
Chart I-4. Structures of the insoluble drugs (albendazole (17) and camptothecin (18)). 
 
1.3.2 Functionalized Cucurbiturils 
 The low solubility of the CB[n] (n = 6, 8, 10) homologues places an unfortunate 
limit on their widespread application. This limitation has led research groups to 















in aqueous and organic solvents. In 2003, Kim and co-workers reported the 
(per)hydroxylation of pre-formed CB[n] macrocycles with varied success (42, 45, 5, and 
4% yields for n = 5-8, respectively).23 (OH)12CB[6], which was obtained in the best yield, 
was further investigated and found to be soluble in organic solvents such as DMSO and 
DMF. The reactivity of the hydroxyl functional group allowed for additional 
derivitization reactions (Scheme I-6 (a)). These compelling CB[n] derivatives lend 
themselves to covalent attachments to glass and silica surfaces, allowing for the 
combination of the microscopic binding properties of CB[n] with macroscopic techniques 
such as chromatography. A mono-substituted CB[n] derivative was reported in 2012, 
when Scherman and co-workers tamed the hydroxylation reaction.24   They were able to 
isolate (OH)1CB[6], which could also be further functionalized. These mono 
functionalized CB[6] derivatives are ideal for highly controlled, single point attachment 
which greatly broadens their potential applications (Scheme I-6 (b)). However, these 
synthetic routes are limited to the smaller CB[5-6] macrocycles, which still leaves a void 





Scheme I-6. Synthesis of functionalized CB[6] derivatives.23,24 
1.3.3 The Building-Block Approach to Functionalized CB[7] 
 
A facile route to CB[7] derivatives was realized by Isaacs and co-workers. The 
essential mechanistic understanding of CB[n] formation provided by Isaacs led to the 
exciting large-scale synthesis of an important synthetic intermediate. In 2011, they 
reported the templated synthesis of acyclic glycoluril hexamer (21) on the gram scale 
(Scheme I-7 (a)).25 Compound 21 was then combined with a functionalized glycoluril 
bis(cyclic ether) (22) to yield a functionalized CB[7]. Isaacs and co-workers reported a 
family of alkylated CB[7] derivatives in 2012 (Scheme I-7 (b)).26 The addition of the 
bulky R groups on the CB[7] derivatives results in incredibly enhanced water solubilities, 
Me2CB[7] (≥264 mM) and CyCB[7] (≥181 mM) which are likely due to interference 
with their ability to form inter-cucurbituril CH---O interactions in the solid state. The 















































































































































investigated and found to be comparable to those of their CB[7] counterpart. Fortunately, 
the alkyl groups were found to enhance the water solubility without affecting the 
molecular recognition of the macrocycles. 
 
Scheme I-7. a) Templated synthesis of acyclic glycoluril hexamer (21). b) Synthesis of 
alkylated CB[7] derivatives. 
 
The enhanced water solubility and expected molecular recognition of Me2CB[7] 
led to the investigation of its use as a molecular container for the previously studied 
albendazole (17) (Figure I-1).26 In a 0.01 M DCl solution in D2O at pD = 2, Me2CB[7] 
performed the same as CB[7] at lower concentrations of host (0-10 mM). Surprisingly, a 
15 mM Me2CB[7] solution was only able to enhance the solubility of 17 to 5.8 mM while 
a CB[7] solution of the same concentration was able to solubilize 1.4 times the amount of 
17 (8.1 mM). Even solutions with very high concentrations of Me2CB[7] (up to 50 mM) 
were unable to enhance the solubility of 17 past ~ 6 mM. This unexpected limitation led 
to the conclusion that the methyl groups are able to enhance the solubility of the free host 




























































































22Me R,R' = Me
22Cy R,R' = -(CH2)4-
22MePh R = Me, R' = Ph
Me2CB[7] R,R' = Me, 31%
CyCB[7] R,R' = -(CH2)4-, 18%





portals, the alkyl groups then act to hinder the solubility of the CB[7]•17 complex. 
Therefore, the design of a suitable excipient for drug delivery must include functional 
groups able to enhance the water solubility beyond simply disrupting the crystal packing 
in order to obtain a soluble host•guest complex.  
 



























Chapter 2: Synthesis and Recognition Properties of a 
Cucurbit[7]uril Derivative Bearing Sulfonate Functional Groups 
 
2.1 Introduction 
It has been reported that the addition of sulfonate groups can be used to highly 
enhance the water solubility of molecular containers, i.e. Captisol™ (>500 mM) and an 
acyclic CB[n]-type molecular container (23) (346 mM), (Chart II-1).27 Sulfonate 
functional groups are ideal due to their biocompatibility. They have very low pKa’s, 
allowing for consistent charge across the biologically relevant pH range. Sulfonate 
functional groups have also been shown to aid in the removal process through urine 
excretion. Accordingly, we hypothesized that a CB[7] derivative bearing sulfonate 
functionality might have high solubility on its own, as well as the host•guest complex 
with insoluble drugs and would therefore be a useful excipient for drug solubilization. 
 
Chart II-1. Chemical structures of molecular containers bearing sulfonate functional 
groups: Captisol™ and an acyclic CB[n]-type molecular container (23). 
 
We decided to use a functionalized bis(cyclic ether) synthetic route similar to the 





























































butanedione (24) with isopropylamine (25) in Et2O with TiCl4 as a catalyst to obtain the 
known diimine (26).28 We then deprotonated 26 with 2.3 equiv. of LDA in THF which 
was followed by dialkylation with 1-chloro-3-iodopropane. Compound 27 was delivered 
in 75% yield after a hydrolytic workup (conditions: 1 M HCl (aq.) addition and CH2Cl2 
extraction) followed by distillation. The functionalized glycoluril (28) was synthesized by 
the condensation reaction of urea and 27 in TFA and benzene at reflux (30% yield). A 
combination of 28 and formalin in HCl resulted in the formation of compound 29 (90% 
yield) which is an ideal SN2 substrate for the introduction of the sulfonate functionality. 
Finally, 29 was treated with Na2SO3 in H2O and converted, almost quantitatively, to 
compound 30 that was isolated in 50% yield. 
  
Scheme II-1. Synthesis of 30. Conditions: (a) Et2O, TiCl4; (b) LDA, THF, Cl(CH2)3I, 
75%; (c) urea, TFA, benzene, reflux, 30%; (d) formalin, HCl, 90%; (e) Na2SO3, H2O, 
50%. 
 
2.2 Synthesis and Purification of Host 1 
We used the unique building-block approach outlined by Isaacs and co-workers to 
obtain a CB[7] derivative with two identical alkyl chains bearing sulfonate functional 
groups by the condensation reaction between 30 and 21 (Scheme II-2). 1H NMR 
























30 R = (CH2)4SO3Na 29 R = (CH2)4Cl 28 R = (CH2)4Cl







reaction mixture by integration of Host 1•16 Ar-H hydrogens of 16 at 6.60 (s, 4H) versus 
that of the methylene/methine C-H hydrogens of Host 1 at 5.35-5.80 (m, 26H). This 
procedure allowed us to determine the composition to be 46% Host 1, 5% CB[6], 49% 
other (Appendix). The crude solid was then dissolved in H2O (5 mL) and loaded onto a 
column (3 cm diameter × 50 cm long) containing 35 cm Dowex 50WX2 ion-exchange 
resin pretreated with H2O and eluted with H2O (600 mL). 1H NMR spectroscopy, in the 
presence of 16, was used to assess the fractional purity, and the appropriate fractions 
were combined. The solvent was removed under reduced pressure. The residue was 
dissolved in H2O (10 mL) and subsequently precipitated in MeOH (40 mL). We collected 
the solid by centrifugation and subsequently suspended it in H2O (5.0 mL). The solution 
was adjusted to pH = 7.0 using a hydroxide solution (0.5 M aq.) with the desired counter 
ion. The solvent was removed under reduced pressure and then dried further under high 
vacuum for 18 hours to give the product as a white solid, 28% yield. 
 
 









































KCl, 12 M HCl
100oC, 30 min
30 R = (CH2)4SO3Na
Host 1 R = (CH2)4SO3Na, 28%
Host 2 R = (CH2)4SO3K, 26%




2.3 Properties of Host 1 
2.2.1 Characterization of Host 1 
 
 Host 1 was fully characterized by IR, 1H NMR, 13C NMR, ESI-MS, and HR-MS 
(see Appendix). As expected, the 1H NMR confirms two equivalent (CH2)4SO3Na arms 
attached to the equatorial position of a glycoluril unit, which can be determined by the 
relative integrations of the signals (14:12:14:4:4:4:4) (Figure II-1 (b)). Also, the increased 
splitting of methylene/methine CH hydrogens on the CB[7] backbone indicates a loss of 
symmetry compared to the singlet and doublets of CB[7]. Upon the addition of 16 the 
upfield-shifted H-atoms of the diastereotopic methylene groups of Host 1 are resolved to 
three doublets of relative intensity 2, and one doublet of relative intensity 1 (Figure II-1 
(a)). This change in the 1H NMR spectra appearance upon the addition of 16 is consistent 
with the previously reported alkylated CB[7] derivatives. 
 
Figure II-1. 1H NMR spectra (400 MHz, D2O, room temperature) recorded for (a) 1:2 
mixture Host 1 (1 mM) and 16 (2 mM) (b) Host 1 (1 mM). 
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2.2.2 Aqueous Solubility Properties of Hosts 1-3  
 
Different counter-ions were investigated to measure their effect on the water 
solubility of the hosts bearing sulfonate functional groups. The ammonium counter-ion 
resulted in a disappointing 15.8 mM solution of Host 3. Host 2 (K+ counter-ion) resulted 
in a slightly better 17.2 mM solution. Surprisingly, the highest water solubility was found 
to be only 20.2 mM with the Na+ counter-ion for Host 1. The addition of the sulfonate 
groups did not enhance the aqueous solubility beyond that of CB[7] (20-30 mM) as 
expected. This unfortunate lack of aqueous solubility enhancement is likely due to the 
hydrophobic nature of the 8 CH2 groups that are added along with the SO3Na groups. 
Container 
hydroxide solution 




Host 1 NaOH 28% 20.2 
Host 2 KOH 26% 17.2 
Host 3 NH4OH 25% 15.8 
 
2.2.3 X-Ray Crystal Structure of Host 1 
We were fortunate to obtain single crystals of the Host 1•16 complex that were 
suitable for structure determination by x-ray crystallography. The structure of one of the 
Host 1•16 complexes indicates a structural similarity to CB[7] (Figure II-2 (a)).14 The 
distance between the ureidyl C=O O-atoms of a single glycoluril unit of Host 1 averages 
6.066 Å (range of 5.884-6.188 Å), comparable to 6.050 Å (range 5.913-6.114 Å) of 
CB[7]. Another similarity is the dimension along the equator of the hosts as seen by the 
distance between the opposing methine C-atoms on every fourth glycoluril: Host 1 
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averages 11.596 Å (range 11.179-11.918 Å), CB[7] average 11.398 Å (range 11.247-
11.516 Å). Another comparison can be made for the distance between the ureidyl C=O 
O-atoms on every fourth glycoluril of one portal, Host 1 averages 8.128 Å (range 7.152-
9.042 Å, standard deviation = 0.746 Å) while CB[7] has an average distance of 8.139 Å 
(range 7.553-8.718 Å, standard deviation = 0.364 Å). The larger range and higher 
standard deviation attributed to Host 1 indicates the glycoluril units pivot slightly where 
one O-atom will shift inward while the other shifts outward, but only to a small extent. 
These slight changes do not appear to significantly alter the molecular structures of the 
cavities of Host 1 as compared to CB[7]. The basic packing of the individual Host 1•16 























Figure II-2. (a) the crystal structure of Host 1•16 and (b) a portion of the crystal lattice 
showing the three-dimensional packing motif down the a-axis. (c) a portion of the crystal 
lattice showing the three-dimensional packing motif down the b-axis. Color code: C, 
grey; H white; N, blue; O, red; S, yellow; H-bonds, orange-striped. 
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2.2.4 Investigation of the Availability of the Cavity of Host 1 for Binding 
 
 1H NMR spectroscopy was used to investigate the potential intermolecular self-
association between the (CH2)4SO3Na arms and an adjacent cavity (Figure II-3). Dilution 
experiments were performed on Host 1 solutions ranging from 16 mM to 130 µM. The 
methylene signals of the (CH2)4SO3Na arms appear at 2.90, 2.40, 1.80, and 1.39 ppm, 
respectively, throughout the concentrations investigated. A lack of upfield shift at any 
concentration indicated the methylene protons are not encapsulated by another Host 1 
compound. These encouraging results indicate the butyl arms are not able to associate 
with the cavity of an adjacent molecule of Host 1 and the cavity is therefore free to 
encapsulate a guest molecule.  
 
Figure II-3. Dilution experiments performed with Host 1 monitored by 1H NMR (D2O, 




2.2.5 Molecular Recognition Properties of Host 1 
Once it was confirmed that the cavity is available for guest complexation, the 
molecular recognition properties of Host 1 were qualitatively investigated. Typical CB[n] 
guests ranging from hexanediamine•2HCl (13) to 1-adamantyl amine•HCl (14) were 
selected for this purpose (Appendix). The binding study for 13 did not reveal any 
surprises. Figure II-4 (b) shows the typical upfield shift for the methylene protons inside 
the cavity. The appearance of sharp signals for both the free and bound guests of a 1:2 
host:guest mixture indicates that the exchange is slow on the 1H NMR chemical shift 
timescale (Figure II-4 (c)). All of the Host 1•guest complexes studied show very similar 
guest resonances to their CB[7]•guest complex counterparts. This similarity indicated 
comparable magnetic environments of the two cavities as we presumed. These reassuring 
results confirm the recognition properties of Host 1 are similar to those of CB[7]. 
 
Figure II-4. 1H NMR spectra (400 MHz, D2O, room temperature) recorded for a mixture 
of (a) 13 (1 mM), (b) 1:1 mixture Host 1 (1 mM) and 13 (1 mM), (c) 1:2 mixture Host 1 
(1 mM) and 13 (2 mM), (d) Host 1 (1 mM). 
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 2.2.6 Drug Solubilization Using Host 1 
Although the expected solubility enhancement of host 1 vs. CB[7] was not 
observed, the molecular recognitions properties of Host 1 appeared to be intact. Therefore 
we decided to investigate the use of Host 1 as an excipient for drug solubilization. 
Perhaps the sulfonate groups could enhance the aqueous solubility of the host•guest 
complex. To test this hypothesis, we constructed phase solubility diagrams.29 To 
construct a phase solubility diagram, a solution of a known concentration of container 
was stirred with an excess of insoluble drug at room temperature in either a 50 mM 
sodium sodium acetate buffer at pD = 4.74 or a 10% DCl solution in D2O until 
equilibrium was reached. The mixtures were then centrifuged and the pellet was 
discarded. The concentrations of the host and drug in the supernatant were determined by 
spiking the 1H NMR samples with a known concentration of MeSO3H or benzene-1,3,5-
tricarboxylate sodium salt as non-binding internal standards.  
The phase solubility diagram of albendazole (17) was obtained in a 50 mM 
sodium acetate buffer at pD = 4.74 revealing the similar binding properties of Host 1 and 
CB[7] (Figure II-5). Eq. 1 assumes 1:1 host:guest binding which should have a linear 
slope where s0 is the intrinsic solubility of the free guest. The graph is linear throughout 
the entire concentration range available at pD = 4.74 which is interpreted as 1:1 
host:guest binding for Host 1 and CB[7] with 17 as expected. The similar slopes for Host 
1 and CB[7] even indicate similar Ka’s. However, the limited water solubility of the hosts 
do not allow for further investigation of the binding properties past the linear region. We 
must conclude that the addition of the sulfonate arms on Host 1 are able to enhance the 
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solubility of 17 to a greater extent than Me2CB[7], but unfortunately are unable to 
enhance the water solubility of the Host 1•17 complex past that of CB[7]•17. 
𝐾! =   
!"#$%
!!(!!!"#$%)
                   (1) 
 
Figure II-5. Phase solubility diagram for 17 with CB[7] and Host 1. 
 
Camptothecin (18) is present in two forms in aqueous solutions, the 
concentrations of which are pH dependent. In solutions of pH > 7.2 the carboxylate is the 
prevalent form while in solutions of pH < 4 the lactone is most prevalent and able to 
associate with a CB[n] host. We wanted to investigate the ability of Host 1 to act as an 
excipient for 18 at a pH slightly greater than 4. Regrettably, the lactone concentration was 
too low in a sodium acetate buffer at pH = 4.74; therefore the phase solubility diagram of 
18 was obtained using a 0.01 M DCl solution in D2O at pD = 2 (Figure II-6). Similar 
association of 18 between Host 1 and CB[7] was also indicated by the linear phase 
solubility diagrams and 1:1 host:guest binding was inferred. The low water solubility of 
the hosts do not allow for further investigation of the binding properties past the linear 
region. Disappointingly, the sulfonate arms are not able to enhance the water solubility of 

























Figure II-6. Phase solubility diagram for 18 with CB[7] and Host 1. 
Interestingly, the phase solubility diagram for the antihistamine cinnarizine (12) 
in a 50 mM sodium acetate buffer at pD = 4.74 shows a significant difference between 
Host 1 and CB[7] complexation (Figure II-7). The phase solubility diagram for CB[7] is 
linear, indicating the expected 1:1 host:guest binding. However, the phase solubility 
diagram for Host 1 indicates a highly reduced solubility for the Host 1•12 complex. This 
is a surprising result since all previously gathered evidence indicates comparable binding 
properties between the similar cavities of Host 1 and CB[7]. Further data was not 
gathered to determine the cause of this change in solubility. 
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In summary, a new difunctionalized cucurbit[7]uril (Host 1) was synthesized 
using the unique building-block approach by the condensation reaction between 
functionalized glycoluril bis(cyclic ether) (30) and glycoluril hexamer (21) in moderate 
yield (28%). Contrary to our hypothesis, the addition of two (CH2)4SO3Na arms did not 
enhance the aqueous solubility of Host 1 relative to CB[7]. The similar molecular 
recognition properties of Host 1, as compared to CB[7], led us to investigate the 
possibility of Host 1 to be a suitable excipient for drug delivery. Unfortunately, the drug 
solubility enhancement studies showed that the addition of the (CH2)4SO3Na arms did 
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General Experimental. Starting materials were purchased from commercial 
suppliers and were used without further purification. N,N’-diisopropyl-1,2-butanediimine 
(24) and glycoluril hexamer (21) were prepared according to literature procedures.1-2 
Melting points were measured on a Meltemp apparatus in open capillary tubes and are 
uncorrected. IR spectra were recorded on a JASCO FT/IR 4100 spectrometer and are 
reported in cm-1. NMR spectra were measured on spectrometers operating at 400 or 500 
MHz for 1H and 100 or 125 MHz for 13C NMR spectra and are reported in ppm. Mass 
spectrometry was performed using a JEOL AccuTOF electrospray instrument (ESI). 
 
Synthetic Procedures and Characterization. 
 
 
Compound 27. A solution of LDA in 
THF/heptane/ethylbenzene (2.0 M, 137 mL, 274 
mmol) was added slowly over 90 min. to a stirring solution of N,N’-diisopropyl-1,2-
butanediimine (20.0 g, 119 mmol) in distilled THF (180 mL) under N2, maintained at -78 
˚C and stirred for an additional 5 h. A solution of 1-chloro-3-iodopropane (57.4 g, 280 
mmol) in distilled THF (20 mL) was added over 15 min. and the mixture was stirred at -
78 ˚C under N2. After 15 h, aqueous HCl (1 M, 600 mL) was added and the mixture was 
allowed to stir at RT for 5 h. THF was removed under reduced pressure, and CH2Cl2 (160 
mL × 3) was used to extract the product from the remaining aqueous layer. The organic 
layers were combined and washed with HCl (1 M, 60 mL), H2O (120 mL), and sat. 
NaHCO3 (120 mL), and the organic layer was then dried over MgSO4. The mixture was 
filtered and the filtrate was concentrated under reduced pressure to yield a crude orange 







(22.5 g, 94.1 mmol, 79%) as a yellow oil. 1H NMR (500 MHz, CDCl3): 3.55 (t, J = 6.3, 
4H), 2.79 (t, J = 7.1, 4H), 1.85-1.70 (m, 8H). 13C NMR (125 MHz, CDCl3): 198.9, 44.4, 
35.1, 31.7, 20.2. ESI-MS: m/z 241 ([M + H]+, calcd. for C10H1735Cl37ClO2+, 241.1755). 
 
Compound 28. Benzene (70 mL) was added to a round bottom 
flask that was equipped with a Dean-Stark apparatus and heated 
to reflux while stirring under N2. After 1 h, 27 (8.00 g, 33.5 
mmol), urea (10.0 g, 167 mmol), and TFA (3.00 mL, 39.2 mmol) 
were added to the round bottom flask. The mixture was refluxed while stirring under N2 
with the Dean-Stark apparatus for 4 h, and then allowed to cool to RT. EtOH (200 mL) 
was added to the round bottom flask, which caused a precipitate to form. The white solid 
was collected by filtration and washed with EtOH (100 mL × 3), and dried under high 
vacuum for 16 h to yield the product as a white powder (3.21 g, 9.94 mmol, 30%). M.p. 
220-222 ˚C. IR (ATR, cm-1): 3206m, 2955w, 1669s, 1497m, 1459m, 1306w, 1174m, 
1108m, 1063m, 1007w. 1H NMR (400 MHz, DMSO-d6): 7.16 (s, 4H), 3.63 (t, J = 6.7, 
4H), 1.73 (q, J = 6.7, 4H) 1.70-1.45 (m, 8H). 13C NMR (100 MHz, DMSO-d6): 159.8, 
77.6, 45.1, 34.0, 32.4, 20.1. ESI-MS: m/z 323 ([M + H]+). HR-MS: m/z 323.1056 ([M + 
H]+, calcd. for C12H2135Cl2N4O2+, 323.1042).  
 
 Compound 29. Compound 28 (8.80 g, 27.2 mmol), formalin 
(37% aqueous solution, 11.0 mL, 147 mmol), and HCl (9 M, 
















with a polyethylene stopper. The mixture was allowed to stir at RT for 20 h and then H2O 
(150 mL) was added. After an additional day of stirring, the precipitate was collected by 
filtration, washed with H2O (100 mL × 3) and dried under high vacuum for 16 h to yield 
the product as a gray solid (10.4 g, 25.8 mmol, 94%). M.p. 134-137 ˚C. IR (ATR, cm-1): 
2950w, 1718s, 1419s, 1236m, 1173s, 1011s, 891s, 722s. 1H NMR (400 MHz, CDCl3): 
5.52 (d, J = 11.4, 4H), 4.75 (d, J = 11.4, 4H), 3.60 (t, J = 6.2, 4H), 2.30-2.20 (m, 4H), 
1.95-1.85 (m, 4H), 1.65-1.50 (m, 4H). 13C NMR (100 MHz, CDCl3): 158.1, 75.7, 71.3, 
44.4, 32.1, 28.7, 21.6. ESI-MS: m/z 407 ([M + H]+). HR-MS: m/z 407.1233 ([M + H]+, 
calcd. for C16H2535Cl2N4O4+, 407.1253). 
 
Compound 30. 29 (3.00 g, 7.37 mmol) and Na2SO3 (4.60 g, 
36.8 mmol) were mixed in a round bottom flask. H2O (60.0 
mL) was added and the mixture was refluxed while stirring 
for 72 h. After cooling to RT the solvent was removed under 
reduced pressure and the solid was stirred in MeOH (100 mL × 3) for 24 h. The mixture 
was filtered and reduced pressure was used to remove MeOH from the combined filtrates 
to yield the product as a white solid (2.00 g, 3.68 mmol, 50%). M.p. >300˚C. IR (ATR, 
cm-1): 2933w, 1743m, 1419m, 1171s, 1034s, 983m, 916m, 735m. 1H NMR (500 MHz, 
D2O): 5.41 (d, J = 10.9, 4H), 5.06 (d, J = 10.9, 4H), 2.96 (t, J = 7.1, 4H), 2.42 (t, J = 8.0 
4H), 1.87 (q, J  = 7.4, 4H), 1.55 (q, J = 7.4, 4H). 13C NMR (125 MHz, D2O, 1,4-dioxane 
as internal reference): 159.0, 76.2, 70.4, 49.9, 27.1, 23.5, 21.6. ESI-MS: m/z 248 ([M – 










((CH2)4SO3-)2 CB[7] Host 1-3. Compound 21 (1.50 g, 1.54 
mmol), KCl (0.229 g, 3.09 mmol), and conc. HCl (7.5 mL) 
were added to a round bottom flask. The mixture was 
stirred at RT for approximately 1 min. until all components 
dissolved, at which time 30 (1.68 g, 3.09 mmol) was added. The flask was then sealed 
with a rubber septum and stirred at 100 °C for 30 min. The reaction mixture was then 
poured into a 50 mL centrifuge tube containing MeOH (40 mL), which resulted in a red-
brown precipitate. The mixture was centrifuged at 7700 rpm for 7 min. The supernatant 
was decanted, and an additional portion of MeOH (40 mL) was added, followed by 
sonication for 10 min. and centrifuged at 7700 rpm for 7 min. This process was repeated 
with two additional portions of MeOH (40 mL). The precipitate was dried under high 
vacuum to give a crude red-brown powder (2.34 g). 1H NMR spectroscopy with 16 was 
used to determine the purity by integration of the Host 1•16 Ar-H hydrogens of 16 at 6.60 
(s, 4H) versus that of the methylene/methine C-H hydrogens of Host 1 at 5.35-5.80 (m, 
26H). This procedure allowed us to calculate that Host 1 comprised 46% of the crude 
solid. The crude solid was dissolved in H2O (5 mL). This solution was loaded onto a 
column (3 cm diameter × 50 cm long) containing 35 cm Dowex 50WX2 ion-exchange 
resin pretreated with H2O. The column was eluted with H2O (600 mL). The fractional 
purity was assessed by 1H NMR in the presence of 16, using the same procedure above, 
and the appropriate fractions were combined. The solvent was removed under reduced 
pressure. H2O (10 mL) was used to dissolve the solid, which was then precipitated in 
MeOH (40 mL). The solid was collected by centrifugation and suspended in H2O (5.0 



































(NaOH for Host 1, KOH for Host 2, NH4OH for Host 3). The solvent was removed under 
reduced pressure and then dried further under high vacuum for 16 h to yield the product 
as a white solid (0.634 g, 0.429 mmol, 28%). Host 1 was fully characterized. M.p. >300 
˚C. IR (ATR, cm-1): 1728m, 1465m, 1322m, 1231m, 1188m, 1035m, 963m, 802s, 759m, 
671m. 1H NMR (400 MHz, D2O, >2 equiv. 16, RT): 7.46 (s, unbound 16), 6.60 (s, bound 
16, 4H), 5.77 (d, J = 15.1, 2H), 5.73 (d, J = 15.1, 4H), 5.70 (d, J = 15.3, 4H), 5.64 (d, J = 
15.3, 4H), 5.57 (d, J = 8.6, 2H), 5.53 (d, J = 8.6, 2H), 5.50-5.35 (m, 8H), 4.29 (d, J = 
15.6, 6H), 4.21 (d, J = 15.6, 4H), 4.13 (d, J = 15.6 4H), 3.91 (s, 4H), 2.92 (t, J = 7.2, 4H), 
2.50-2.30 (m, 4H), 1.90-1.75 (m, 4H), 1.50-1.30 (m, 4H). 13C NMR (125 MHz, D2O, 1,4-
dioxane as internal reference, >1 equiv 16, RT): 156.2, 156.1, 155.9, 155.9, 133.0, 128.9, 
127.3, 79.8, 71.3, 71.0, 70.9, 70.8, 70.6, 70.4, 52.6, 52.0, 51.7, 49.7, 48.7, 42.2, 42.1, 
41.9, 41.8, 26.7, 23.4, 20.3, 19.2. ESI-MS: m/z 786 ([M•16 – 2Na +4H]2+). HR-MS: m/z 
786.2488 ([M – 2Na + PXDA +4H]2+, calcd. for [C58H72N30O20 S2 ]2+, 786.2490). The 1H 
NMR spectra for Hosts 2 and 3 in the presence of 16 were congruent with that of Host 1.  
 
References:  
1. N. D. Kimpe, L. D’Hondt, E. Stanoeva, Tetrahedron Lett. 1991, 32, 3879-3882. 






Figure S-1. 1H NMR spectrum recorded (400 MHz, D2O, RT) for the crude reaction 
mixture from the reaction between 21 and 30 in the presence of 16 as a probe. 1H NMR 
integration of the 16 binding region (6-7 ppm) versus the methylene/methine region of 
Host 1 (5.4-5.8 ppm) allows us to determine the contents of the crude mixture (46% Host 

















































Figure S9. 13C NMR spectrum recorded (125 MHz, D2O, 1,4-dioxane as internal 

















Figure S12. 13C NMR spectrum recorded (125 MHz, D2O, 1,4-dioxane as internal 






Procedure to test the solubility of Hosts 1-3 in water. An excess of the host compound 
was added into 1 mL D2O and magnetically stirred at room temperature for 16 h. The 
mixture was then centrifuged for two 10 min segments at 4400 rpm. A portion of the 
supernatant (420 µL) was combined with MeSO3H (200 mM, 40 µL in D2O). The 
concentration of 1 was determined by the comparison of 1H NMR resonance integrations 
of MeSO3H (2.78 ppm) versus the methylene/methine H-atoms of Host 1 (5.52-5.77 






Figure S13. 1H NMR spectra recorded (D2O, 400 MHz, RT, 200 mM MeSO3H as 







Figure S14. 1H NMR spectra recorded (D2O, 400 MHz, RT) for a) 13 (1 mM), b) a 1:1 
mixture of Host 1 (1 mM) and 13 (1 mM), c) a 1:2 mixture of Host 1 (1 mM) and 13 (2 





Figure S15. 1H NMR spectra recorded (D2O, 400 MHz, RT) for a) 
cyclohexanediamine•2HCl (1 mM), b) a 1:1 mixture of Host 1 (1 mM) and 
cyclohexanediamine•2HCl (1 mM), c) a 1:2 mixture of Host 1 (1 mM) and 







Figure S16. 1H NMR spectra recorded (D2O, 400 MHz, RT) for a) spermine•4HCl (1 
mM), b) a 1:1 mixture of Host 1 (1 mM) and spermine•4HCl (1 mM), c) a 1:2 mixture of 





Figure S17. 1H NMR spectra recorded (D2O, 400 MHz, RT) for a) 14 (1 mM), b) a 1:1 
mixture of Host 1 (1 mM) and 14 (1 mM), c) a 1:2 mixture of Host 1 (1 mM) and 14 (2 





Figure S18. 1H NMR spectra recorded (D2O, 400 MHz, RT) for a) 16, b) a 1:1 mixture 
of Host 1 (1 mM) and 16 (1 mM), c) a 1:2 mixture of Host 1 (1 mM) and 16 (2 mM), d) 






Figure S19. 1H NMR spectra recorded (D2O, 400 MHz, RT) for a) 15 (1 M), b) a 1:1 
mixture of Host 1 (1 mM) and 15 (1 mM), c) a 1:2 mixture of Host 1 (1 mM) and 15 (2 





Figure S20. 1H NMR spectra recorded (D2O, 400 MHz, RT) for a) methyl viologen•2Cl- 
(1 mM), b) a 1:1 mixture of Host 1 (1 mM) and methyl viologen•2Cl- (1 mM), c) a 1:2 





Figure S21. 1H NMR spectra recorded (D2O, 400 MHz, RT) for a) adamantyl 
pyridine•Br- (1 mM), b) a 1:1 mixture of Host 1 (1 mM) and adamantyl pyridine•Br- (1 




Procedure to measure the solubility of drugs with CB[7] and Host 1.  An excess of 
solid drug was added to a solution of a known concentration of the host container in a 50 
mM sodium sodium acetate buffer, pD = 4.74 (18 was also tested in a 0.01 M DCl 
solution at pD = 2) The mixtures were stirred at room temperature for 16 h to reach 
equilibria. The mixtures were then centrifuged at 4400 rpm for two 10 min segments and 
the pellet containing the insoluble drug + drug•host complex was discarded. The 
supernatant was spiked with a known concentration of an internal standard (17 and 18: 
MeSO3H, 12: benzene-1,3,5-tricarboxylate sodium salt) and the concentrations of the 
host and drug were determined by the comparison of 1H NMR resonance integration of 
the drug (17 triplet at -0.12 ppm, 18 triplet at 1.01 ppm, 12 resonances between 6.4 and 






Figure S22. 1H NMR spectra recorded (D2O, 400 MHz, RT) for 17 and Host 1 using 




Figure S23. 1H NMR spectra recorded (D2O, 400 MHz, RT) for 18 and Host 1 using 






Figure S24. 1H NMR spectra recorded (D2O, 400 MHz, RT) for 12 and Host 1 using 










Figure S25. Phase solubility diagram for 17 with CB[7] and Host 1 (50 mM sodium 





Figure S26. Phase solubility diagram for 18 with CB[7] and Host 1 (50 mM sodium 
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Figure S27. Phase solubility diagram for 12 with CB[7] and Host 1 (50 mM sodium 
acetate buffer, pD = 4.74.1. 
 
 
Figure S28. Phase solubility diagram for 12 and Host 1 (50 mM sodium acetate buffer, 















































Details of the crystal structure of Host 1 
Performed by Peter Zavalij 
A colorless prism-like specimen of C58H112N30O41S2, approximate dimensions 
0.13 mm × 0.22 mm × 0.30 mm, was used for the X-ray crystallographic analysis. The X-
ray intensity data were measured on a Bruker APEX-II CCD system equipped with a 
graphite monochromator and a MoKα sealed tube (λ = 0.71073 Å). Data collection 
temperature was 150 K. 
The total exposure time was 18.50 hours. The frames were integrated with the 
Bruker SAINT software package using a narrow-frame algorithm. The integration of the 
data using an orthorhombic unit cell yielded a total of 109234 reflections to a maximum θ 
angle of 25.00° (0.84 Å resolution), of which 30342 were independent (average 
redundancy 3.600, completeness = 99.9%, Rint = 7.13%) and 19333 (63.72%) were 
greater than 2σ(F2). The final cell constants of a = 13.2943(11) Å, b = 21.6007(17) Å, c = 
60.158(5) Å, V = 17275.(2) Å3, are based upon the refinement of the XYZ-centroids of 
9971 reflections above 20 σ(I) with 4.503° < 2θ < 40.53°. Data were corrected for 
absorption effects using the multi-scan method (SADABS). The calculated minimum and 
maximum transmission coefficients (based on crystal size) are 0.8830 and 0.9790. 
The structure was solved and refined using the Bruker SHELXTL Software 
Package, using the space group P212121, with Z = 8 for the formula unit, 
C58H112N30O41S2. The final anisotropic full-matrix least-squares refinement on F2 with 
2098 variables converged at R1 = 7.31%, for the observed data and wR2 = 14.87% for all 
data. The goodness-of-fit was 1.002. The largest peak in the final difference electron 
density synthesis was 0.492 e-/Å3 and the largest hole was -0.394 e-/Å3 with an RMS 
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deviation of 0.059 e-/Å3. On the basis of the final model, the calculated density was 1.499 
g/cm3 and F(000), 8240 e-. 
Crystallographic References: APEX2 Version 2010.11-3 (Bruker AXS Inc.) 
 SAINT Version 7.68A (Bruker AXS Inc., 2009)  SADABS Version 2008/1 (G. M. 
Sheldrick, Bruker AXS Inc.)  XPREP Version 2008/2 (G. M. Sheldrick, Bruker AXS 
Inc.)  XS Version 2008/1 (G. M. Sheldrick, Acta Cryst. (2008). A64, 112-122)  XL 
Version 2012/4 (G. M. Sheldrick, (2012) University of Gottingen, Germany)  Platon (A. 
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Table S2. Data collection and structure refinement for UM2475. 
Diffractometer Bruker APEX-II CCD 
Radiation source sealed tube, MoKα 
Theta range for data collection 1.65 to 25.00° 
Index ranges -15 ≤ h ≤ 15, -25 ≤ k ≤ 25, -71 ≤ l ≤ 71 
Reflections collected 109234 
Independent reflections 30342 [R(int) = 0.0713] 
Coverage of independent reflections 99.9% 
Absorption correction multi-scan 
Table S1. Sample and crystal data for UM2475. 
Identification code 2475 
Chemical formula C58H112N30O41S2 
Formula weight 1949.89 
Temperature 150(2) K 
Wavelength 0.71073 Å 
Crystal size 0.13 × 0.22 × 0.30 mm 
Crystal habit colorless prism 
Crystal system orthorhombic 
Space group P212121 
Unit cell dimensions a = 13.2943(11) Å α = 90° 
 b = 21.6007(17) Å β = 90° 
 c = 60.158(5) Å γ = 90° 
Volume 17275.(2) Å3  
Z 8 
Density (calculated) 1.499 Mg/cm3 




Max. and min. transmission 0.9790 and 0.8830 
Structure solution technique direct methods 
Structure solution program ShelXS-97 (Sheldrick, 2008) 
Refinement method Full-matrix least-squares on F2 
Refinement program ShelXL-2012 (Sheldrick, 2012) 
Function minimized Σ w(Fo2 - Fc2)2 
Data / restraints / parameters 30342 / 716 / 2098 
Goodness-of-fit on F2 1.002 
Δ/σmax 0.001 
Final R indices 19333 data; I>2σ(I)  R1 = 0.0731, wR2 = 0.1374  
 all data                      R1 = 0.1085, wR2 = 0.1487   
Weighting scheme w=1/[σ
2(Fo2)+(0.0150P)2+31.8000P] ,  
P=(Fo2+2Fc2)/3 
Absolute structure parameter 0.1(1) 
Largest diff. peak and hole 0.492 and -0.394 eÅ-3 
R.M.S. deviation from mean 0.059 eÅ-3 
 
Rint = Σ|Fo2 - Fo2(mean)| / Σ[Fo2]  
R1 = Σ||Fo| - |Fc|| / Σ|Fo|  
GOOF = S = {Σ[w(Fo2 - Fc2)2] / (n - p)}1/2  
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